(Q37823843)

23 August 2017

1 reference

title

Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer (English)

1 reference

23 August 2017

1 reference

1 reference

3

0 references

Bernd Hamm

series ordinal

2

object named as

Bernd Hamm

1 reference

23 August 2017

Tobias Franiel

1

1 reference

23 August 2017

language of work or name

English

0 references

publication date

24 December 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

21

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

616-626

1 reference

23 August 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Imaging prostate cancer: a multidisciplinary perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Endorectal MR imaging before salvage prostatectomy: tumor localization and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Functional MR imaging of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

The role of intravenous contrast enhancement in magnetic resonance imaging of prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Angiogenesis in prostate cancer: biology and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Topography of neovascularity in human prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Prognostic value of microvessel density in prostate cancer: a tissue microarray study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Implementation of a rapid inversion-prepared dual-contrast gradient echo sequence for quantitative dynamic contrast-enhanced magnetic resonance imaging of the human prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Combined T2* and T1 measurements for improved perfusion and permeability studies in high field using dynamic contrast enhancement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Reference tissue quantification of DCE-MRI data without a contrast agent calibration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Rapid high-resolution T(1) mapping by variable flip angles: accurate and precise measurements in the presence of radiofrequency field inhomogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

The importance of correct norms in blood volume measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Methodological approaches to quantitative evaluation of microcirculation in tissues with dynamic magnetic resonance tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Microvascular permeability of normal and neoplastic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: II. Experimental validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Precision in measurements of perfusion and microvascular permeability with T1-weighted dynamic contrast-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Simultaneous quantification of perfusion and permeability in the prostate using dynamic contrast-enhanced magnetic resonance imaging with an inversion-prepared dual-contrast sequence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Theory of the measurement of blood flow by the dilution of an indicator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

MRI of prostate cancer at 1.5 and 3.0 T: comparison of image quality in tumor detection and staging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Imaging for recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Artifacts and pitfalls in MR imaging of the pelvis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Active surveillance for early-stage prostate cancer: review of the current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

A zero PSA slope in posttreatment prostate-specific antigen supports cure of patients with long-term follow-up after external beam radiotherapy for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Angiogenesis as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Angiogenesis inhibitors in the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Accelerated parallel imaging by transform coding data compression with k-t SENSE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2037-7

Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression.

21 January 2018

1 reference

12 December 2020

Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI.

1 reference

12 December 2020

Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma

1 reference

12 December 2020

Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy

1 reference

12 December 2020

Comparison of microscopic vascularity in benign and malignant prostate tissue

1 reference

12 December 2020

Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era

1 reference

12 December 2020

Transient elevation of serum prostate-specific antigen following (125)I/(103)Pd brachytherapy for localized prostate cancer

1 reference

12 December 2020

Patterns and fate of PSA bouncing following 3D-CRT

1 reference

12 December 2020

Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment

1 reference

12 December 2020

Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature

1 reference

12 December 2020

MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo

1 reference

12 December 2020

Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model

1 reference

12 December 2020

Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging

1 reference

12 December 2020

Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate

1 reference

12 December 2020

Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging.

1 reference

12 December 2020

Dynamic contrast-enhanced MRI for prostate cancer localization

1 reference

12 December 2020

Pharmacokinetic parameters as a potential predictor of response to pharmacotherapy in benign prostatic hyperplasia: a preclinical trial using dynamic contrast-enhanced MRI

1 reference

12 December 2020

[Pharmacokinetic MRI of the prostate: parameters for differentiating low-grade and high-grade prostate cancer].

1 reference

12 December 2020

Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences.

1 reference

12 December 2020

Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters

1 reference

12 December 2020

Evaluation of the prostate and prostatic carcinoma with gadolinium-enhanced endorectal coil MR imaging

1 reference

12 December 2020

Molecular markers and mortality in prostate cancer

1 reference

12 December 2020

Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers

1 reference

12 December 2020

Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Localization of Recurrent Prostate Cancer After External Beam Radiotherapy

1 reference

12 December 2020

Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging

1 reference

12 December 2020

Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.

1 reference

12 December 2020

Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parameters

1 reference

12 December 2020

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis

1 reference

12 December 2020

Dynamic contrast-enhanced MRI using Gd-DTPA: interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors

1 reference

12 December 2020

Evaluation and treatment of men with biochemical prostate-specific antigen recurrence following definitive therapy for clinically localized prostate cancer

1 reference

12 December 2020

Commentary on a multi-institutional analysis of external beam radiotherapy for T1–T2 prostate cancer: “love the one you're with” and “do the right thing”

1 reference

12 December 2020

Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy

1 reference

12 December 2020

Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging

1 reference

12 December 2020

Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy

1 reference

12 December 2020

Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.

1 reference

12 December 2020

Serial biopsy results in prostate cancer screening study

1 reference

12 December 2020

Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging

1 reference

12 December 2020

Prostate cancer detection with multi-parametric MRI: Logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI

1 reference

12 December 2020

Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues

1 reference

12 December 2020

Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging

1 reference

12 December 2020

Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor--correlation with biopsy findings

1 reference

12 December 2020

Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens?

1 reference

12 December 2020

Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy.

1 reference

12 December 2020

Accurate estimation of pharmacokinetic contrast-enhanced dynamic MRI parameters of the prostate

1 reference

12 December 2020

The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy

1 reference

12 December 2020

Evaluation of the anti-vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI.

1 reference

12 December 2020

Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging

1 reference

12 December 2020

Placental perfusion and permeability: simultaneous assessment with dual-echo contrast-enhanced MR imaging in mice

1 reference

12 December 2020

Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values

1 reference

12 December 2020

10.1007/S00330-010-2037-7

Identifiers

DOI

1 reference

23 August 2017

1 reference